

The Post-EBMT VJSessions from VJHemOnc
Apr 7, 2021
Guest Christian Chabannon, MD, PhD, chairs a discussion on the takeaways from the EBMT 2021 meeting, including updates in conditioning, managing graft-versus-host disease, transplantation in rarer hematological malignancies, and immune effector cell therapies.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Comparing Treatment Strategies for GVHD Prophylaxis
03:17 • 12min
Targeting Graft-Versus-Host Disease and the Role of ECP
15:44 • 4min
Rook Solitinip Pretreatment and Transplant Outcomes
19:45 • 12min
Real-World Experience with CAR-T Cells and the Future of Immune Effector Cell Therapies
31:39 • 3min